Nanalysis Scientific Corp.
NSCIF
$0.13
$0.016.08%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.99% | -68.41% | 82.89% | -341.64% | 17.32% |
| Total Depreciation and Amortization | -16.48% | 9.78% | -26.86% | -61.86% | 1.29% |
| Total Amortization of Deferred Charges | -15.14% | 22.81% | -18.79% | -- | -- |
| Total Other Non-Cash Items | -53.69% | -26.79% | -93.42% | 740.31% | -10.01% |
| Change in Net Operating Assets | 114.79% | -136.42% | 430.14% | 7.65% | -192.75% |
| Cash from Operations | 80.21% | -160.71% | 144.91% | 421.88% | -130.71% |
| Capital Expenditure | 58.51% | -67.29% | -- | 100.00% | -528.57% |
| Sale of Property, Plant, and Equipment | -98.51% | 571.43% | -90.93% | 321.86% | -28.52% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.01% | 32.14% | -49.54% | 19.81% | 14.92% |
| Cash from Investing | 4.95% | 33.34% | -134.26% | 42.00% | 12.83% |
| Total Debt Issued | -41.72% | -- | -- | 35.44% | -- |
| Total Debt Repaid | 128.57% | 95.05% | -139.91% | 2.84% | -23.42% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.31% | -16.37% | -1.80% | 11.90% | 7.69% |
| Cash from Financing | -53.69% | 159.08% | -925.94% | 282.07% | 84.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 118.25% | 43.70% | -156.59% | 224.41% | -59.50% |